Safety and antitumor activity of selinexor (KPT-330), a first-in -class, oral XPO1 selective inhibitor of nuclear export: A phase I study expanded with colon cancer cohort Meeting Abstract
| Authors: | Mau-Soerensen, M.; Razak, A. R. A.; Mahipal, A.; Mahaseth, H.; Gerecitano, J. F.; Shacham, S.; Yau, C. Y. F.; Lassen, U.; Shields, A. F.; McCauley, D.; Cooksey, J.; Tan, D. S. P.; Rashal, T.; Shacham, E.; Landesman, Y.; Pond, G.; Oza, A. M.; Kauffman, M.; Siu, L.; Mirza, M. R. |
| Abstract Title: | Safety and antitumor activity of selinexor (KPT-330), a first-in -class, oral XPO1 selective inhibitor of nuclear export: A phase I study expanded with colon cancer cohort |
| Meeting Title: | 2014 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2014 Jan 16-18 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-01-01 |
| Language: | English |
| ACCESSION: | WOS:000333682100474 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.3_suppl.482 |
| Notes: | Meeting Abstract: 482 -- Gastrointestinal Cancers Symposium -- JAN 16-18, 2014 -- San Francisco, CA -- S -- Source: Wos |
